{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:36:07Z","timestamp":1794659767933,"version":"4.9.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/rlu.0000000000001395","type":"journal-article","created":{"date-parts":[[2016,9,17]],"date-time":"2016-09-17T16:15:02Z","timestamp":1474128902000},"page":"837-843","source":"Crossref","is-referenced-by-count":18,"title":["Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?"],"prefix":"10.1097","volume":"41","author":[{"given":"Marius E.","family":"Mayerhoefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Karanikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Kletter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kiesewetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Pones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Simonitsch-Klupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Dolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Raderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210204","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"R2-1-20210204","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"R3-1-20210204","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/RLU.0000000000001005","article-title":"Does delayed-time-point imaging improve 18F-FDG-PET in patients with MALT lymphoma? Observations in a series of 13 patients","volume":"41","author":"Mayerhoefer","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R4-1-20210204","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/cancers7010287","article-title":"FDG-PET response prediction in pediatric Hodgkin\u2019s lymphoma: impact of metabolically defined tumor volumes and individualized SUV measurements on the positive predictive value","volume":"7","author":"Hussien","year":"2015","journal-title":"Cancers (Basel"},{"key":"R5-1-20210204","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1200\/JCO.2008.19.7814","article-title":"Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin\u2019s lymphoma: analysis of a prospective multicenter trial","volume":"27","author":"Furth","year":"2009","journal-title":"J Clin Oncol"},{"key":"R6-1-20210204","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1182\/blood-2010-12-327767","article-title":"SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma","volume":"118","author":"Casasnovas","year":"2011","journal-title":"Blood"},{"key":"R7-1-20210204","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2967\/jnumed.107.042093","article-title":"Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis","volume":"48","author":"Lin","year":"2007","journal-title":"J Nucl Med"},{"key":"R8-1-20210204","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1007\/s00259-013-2435-6","article-title":"An international confirmatory study of the prognostic value of early PET\/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and \u0394SUVmax","volume":"40","author":"Itti","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-1-20210204","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/RLU.0000000000000892","article-title":"The Deauville 5-point scale improves the prognostic value of interim FDG PET\/CT in extranodal natural killer\/T-cell lymphoma","volume":"40","author":"Jiang","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R10-1-20210204","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00330-010-1758-y","article-title":"Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma","volume":"20","author":"Lin","year":"2010","journal-title":"Eur Radiol"},{"key":"R11-1-20210204","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2214\/AJR.10.4743","article-title":"Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG-PET\/CT","volume":"196","author":"van Ufford","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"R12-1-20210204","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1258\/ar.2010.100246","article-title":"Whole-body diffusion-weighted imaging compared with FDG-PET\/CT in staging of lymphoma patients","volume":"52","author":"Abdulqadhr","year":"2011","journal-title":"Acta Radiol"},{"key":"R13-1-20210204","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.ejrad.2013.05.042","article-title":"Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas","volume":"82","author":"St\u00e9phane","year":"2013","journal-title":"Eur J Radiol"},{"key":"R14-1-20210204","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1158\/1078-0432.CCR-13-3355","article-title":"Evaluation of diffusion-weighted magnetic resonance imaging for pre-therapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients","volume":"20","author":"Mayerhoefer","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R15-1-20210204","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/nbm.3105","article-title":"Diffusion-weighted MRI for staging and evaluation of response in diffuse large B-cell lymphoma: a pilot study","volume":"27","author":"Siegel","year":"2014","journal-title":"NMR Biomed"},{"key":"R16-1-20210204","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/RLI.0b013e3182087b03","article-title":"Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study","volume":"46","author":"Lin","year":"2011","journal-title":"Invest Radiol"},{"key":"R17-1-20210204","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1102\/1470-7330.2013.0006","article-title":"Whole-body diffusion-weighted magnetic resonance imaging at 3 Tesla for early assessment of treatment response in non-Hodgkin lymphoma: a pilot study","volume":"13","author":"De Paepe","year":"2013","journal-title":"Cancer Imaging"},{"key":"R18-1-20210204","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/nbm.2933","article-title":"Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma\u2014a whole-body MRI and diffusion-weighted imaging study","volume":"26","author":"Wu","year":"2013","journal-title":"NMR Biomed"},{"key":"R19-1-20210204","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-14-2454","article-title":"Evaluation of diffusion-weighted magnetic resonance imaging for follow-up and treatment response assessment of lymphoma: results of an 18F-FDG-PET\/CT-controlled prospective study in 64 patients","volume":"21","author":"Mayerhoefer","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R20-1-20210204","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/nbm.1689","article-title":"Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma\u2014a pilot study: comparison with 2-deoxy-2-fluoro-D-glucose-positron emission tomography\/computed tomography","volume":"24","author":"Wu","year":"2011","journal-title":"NMR Biomed"},{"key":"R21-1-20210204","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.mri.2011.09.019","article-title":"The clinical application of whole-body diffusion-weighted imaging in the early assessment of chemotherapeutic effects in lymphoma: the initial experience","volume":"30","author":"Chen","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"R22-1-20210204","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0284185114526087","article-title":"Diffusion-weighted MRI compared to FDG PET\/CT for assessment of early treatment response in lymphoma","volume":"56","author":"Hagtvedt","year":"2015","journal-title":"Acta Radiol"},{"key":"R23-1-20210204","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.09090021","article-title":"Diffusion-weighted MR imaging of the liver","volume":"254","author":"Taouli","year":"2010","journal-title":"Radiology"},{"key":"R24-1-20210204","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2214\/ajr.178.5.1781117","article-title":"Gastric mucosa-associated lymphoid tissue lymphoma: helical CT findings and pathologic correlation","volume":"178","author":"Choi","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"R25-1-20210204","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1158\/1078-0432.CCR-06-0066","article-title":"Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity","volume":"12","author":"van Meerten","year":"2006","journal-title":"Clin Cancer Res"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:16:43Z","timestamp":1620973003000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201611000-00001"}},"subtitle":["A Preliminary Study in 15 Patients"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001395","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}